Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Cytarabine And Mitoxantrone Therapy For Relapsed And Refractory Acute Myeloid And Lymphocytic Leukemia: Effects Of GM-CSF Versus G-CSF
NCT00053131Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jan 1999
- Primary completion
- Feb 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim, sargramostim in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Roswell Park Comprehensive Cancer Center. Started Jan 1999; status: completed.
02
Drugs
filgrastimsargramostim
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00053131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053131.